Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Chu Hsien Lim

56 indexed publications match this author name.

ORCID: 0000-0001-6691-8277
OpenAlex: https://openalex.org/A5024250797

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 19 Review Article 18 Safety 16 Mechanism of Action 12 Animal Study 11 Receptor Pharmacology 11 Anxiety 9 Clinical Trial 9 PTSD 8 Neuroplasticity 8 Systematic Review 8 General 7

Journals

ClinicalTrials.gov 5 Journal of Drug Delivery Science and Technology 2 ACS Omega 2 Psychopharmacology 2 Frontiers in psychiatry 2 bioRxiv 2 Drugs and Drug Candidates 1 Open MIND 1

Publication history

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12 Is BOLD Measurement-Invariant Across Pharmacological State? A Pre-Registered Test of Haemodynamic Response Function Drug-Invariance Using Simultaneous EEG-fMRI (PsiConnect)Open MIND · 2026-07-28 Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22 Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15 Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-06-01 The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08 Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-05-01 Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.Science advances · 2026-04-03 Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01 The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-01 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.Open Access CRIS of the University of Bern · 2026-01-21 Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20 Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb PainClinicalTrials.gov · 2026-01-09 Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02 COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01 Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal ExtractJournal of the Brazilian Chemical Society · 2026-01-01 Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challengesAdvanced Neurology · 2025-12-04 Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-30 The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.ClinicalTrials.gov · 2025-09-15 Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-22 Chemical Composition and Biological Activities of Mushrooms: Gaps and Perspectives.Pharmaceuticals (Basel, Switzerland) · 2025-07-01 Innovation and inequity in psychedelic research at the Mayo Clinic.History of psychiatry · 2025-06-01 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Palliative & supportive care · 2025-04-22 Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters.Scientific reports · 2025-04-22 Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their ImplicationsPharmaceuticals · 2025-03-07 The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10 PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERSHealth and Society · 2025-01-08 Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.International journal of medicinal mushrooms · 2025-01-01 Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.Therapeutic advances in psychopharmacology · 2025-01-01 Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius haematocephalusBrazilian Journal of Science · 2024-11-01 In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.Psychopharmacology · 2024-06-01 Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology · 2024-05-31 Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice.Journal of psychopharmacology (Oxford, England) · 2024-05-01 Rapid-acting antidepressant drugs modulate affective bias in rats.Science translational medicine · 2024-01-10 Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybinJournal of Drug Delivery Science and Technology · 2024-01-06 Ayahuasca for the treatment of alcohol use disorder.International review of neurobiology · 2024-01-01 Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity.Chinese medical journal · 2023-12-20 An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.The American journal of hospice & palliative care · 2023-11-01 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24 Manic episode following psilocybin use in a man with bipolar II disorder: a case report.Frontiers in psychiatry · 2023-01-01 An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)ClinicalTrials.gov · 2022-10-12 Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current researchAddiction Neuroscience · 2022-06-22 Analysis of recreational psychedelic substance use experiences classified by substance.Psychopharmacology · 2022-02-01 The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological PhenotypebioRxiv · 2021-03-08 Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of clinical psychopharmacology · 2021-01-01 Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in psychiatry · 2021-01-01 The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.Frontiers in pharmacology · 2021-01-01 Psilocybin rescues sociability deficits in an animal model of autismbioRxiv · 2020-09-10 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 Restructuring consciousness -the psychedelic state in light of integrated information theory.Frontiers in human neuroscience · 2015-01-01 A fatal case of 'magic mushroom' ingestion in a heart transplant recipient.Internal medicine journal · 2012-10-31 Long-lasting behavioral effects of bromocriptine in cats.European journal of pharmacology · 1984-07-13

Author directory